Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jul. 02, 2017 | Aug. 04, 2017 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | QUANTENNA COMMUNICATIONS INC | |
Entity Central Index Key | 1,370,702 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Jul. 2, 2017 | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Entity common stock, shares outstanding | 34,630,127 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Current assets | ||
Cash and cash equivalents | $ 58,231 | $ 117,045 |
Marketable securities | 66,158 | 0 |
Accounts receivable | 17,696 | 14,480 |
Inventory | 20,985 | 15,820 |
Prepaid expenses and other current assets | 4,332 | 2,470 |
Total current assets | 167,402 | 149,815 |
Property and equipment, net | 6,380 | 4,742 |
Other long-term assets | 769 | 232 |
Total assets | 174,551 | 154,789 |
Current liabilities | ||
Accounts payable | 10,527 | 7,776 |
Accrued liabilities and other current liabilities | 22,021 | 11,801 |
Long-term debt, current portion | 2,563 | 2,257 |
Total current liabilities | 35,111 | 21,834 |
Long-term debt | 2,445 | 3,680 |
Other long-term liabilities | 425 | 527 |
Total liabilities | 37,981 | 26,041 |
Commitments and contingencies (see Note 6) | ||
Stockholders’ equity | ||
Common stock: $0.0001 par value, 1,000,000,000 shares authorized at July 2, 2017 and January 1, 2017, 34,449,536 and 33,076,150 shares issued and outstanding at July 2, 2017 and January 1, 2017, respectively | 3 | 3 |
Additional paid-in capital | 298,943 | 290,319 |
Accumulated other comprehensive loss | (32) | 0 |
Accumulated deficit | (162,344) | (161,574) |
Total stockholders’ equity | 136,570 | 128,748 |
Total liabilities and stockholders’ equity | $ 174,551 | $ 154,789 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jul. 02, 2017 | Jan. 01, 2017 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (usd per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued (in shares) | 34,449,536 | 33,076,150 |
Common stock, shares outstanding (in shares) | 34,449,536 | 33,076,150 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Income Statement [Abstract] | ||||
Revenue | $ 47,085 | $ 33,035 | $ 84,976 | $ 57,472 |
Cost of revenue | 23,314 | 16,671 | 42,621 | 29,205 |
Gross profit | 23,771 | 16,364 | 42,355 | 28,267 |
Operating expenses: | ||||
Research and development | 16,055 | 11,524 | 28,688 | 21,751 |
Sales and marketing | 3,276 | 1,769 | 6,191 | 3,399 |
General and administrative | 4,106 | 2,993 | 7,496 | 4,555 |
Total operating expenses | 23,437 | 16,286 | 42,375 | 29,705 |
Income (loss) from operations | 334 | 78 | (20) | (1,438) |
Interest expense | (141) | (111) | (339) | (225) |
Other income (expense), net | 186 | (180) | 387 | (248) |
Income (loss) before income taxes | 379 | (213) | 28 | (1,911) |
Provision for income taxes | (210) | (21) | (744) | (38) |
Net income (loss) | $ 169 | $ (234) | $ (716) | $ (1,949) |
Net income (loss) per share: | ||||
Basic (usd per share) | $ 0 | $ (0.22) | $ (0.02) | $ (1.83) |
Diluted (usd per share) | $ 0 | $ (0.22) | $ (0.02) | $ (1.83) |
Weighted average shares used to compute basic and diluted net income (loss) per share: | ||||
Basic (in shares) | 33,881,039 | 1,075,323 | 33,493,778 | 1,062,606 |
Diluted (in shares) | 38,475,450 | 1,075,323 | 33,493,778 | 1,062,606 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income (loss) | $ 169 | $ (234) | $ (716) | $ (1,949) |
Other comprehensive loss, net of tax: | ||||
Unrealized losses on available-for-sale marketable securities | (32) | 0 | (32) | 0 |
Comprehensive income (loss) | $ 137 | $ (234) | $ (748) | $ (1,949) |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Jul. 02, 2017 | Jun. 26, 2016 | |
Cash flows from operating activities | ||
Net loss | $ (716) | $ (1,949) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 1,024 | 537 |
Stock-based compensation expense | 4,678 | 1,190 |
Non-cash interest expense, net | 197 | 30 |
Change in fair value of convertible preferred stock warrants liability | 0 | 45 |
Changes in assets and liabilities | ||
Accounts receivable | (3,216) | (5,096) |
Inventory | (5,165) | (42) |
Prepaid expenses and other current assets | (1,898) | (42) |
Other assets | (537) | (55) |
Accounts payable | 2,652 | (3,589) |
Accrued liabilities and other current liabilities | 9,913 | 5,009 |
Net cash provided by (used) in operating activities | 6,932 | (3,962) |
Cash flows from investing activities | ||
Purchase of property and equipment | (2,446) | (626) |
Purchase of marketable securities | (71,169) | 0 |
Proceeds from sales of marketable securities | 4,994 | 0 |
Restricted cash | 0 | (1,500) |
Net cash used in investing activities | (68,621) | (2,126) |
Cash flows from financing activities | ||
Proceeds from issuance of common stock | 4,076 | 88 |
Payments of offering costs | (96) | 0 |
Proceeds from revolving line of credit, net of fees paid | 0 | 2,950 |
Proceeds from issuance of long-term debt, net of fees paid | 0 | 3,854 |
Repayments of long-term debt | (1,105) | (2,711) |
Net cash provided by financing activities | 2,875 | 4,181 |
Net decrease in cash and cash equivalents | (58,814) | (1,907) |
Beginning of period | 117,045 | 18,850 |
End of period | 58,231 | 16,943 |
Supplemental disclosure of cash flow information | ||
Interest paid during the period | 290 | 321 |
Income taxes paid during the period | 633 | 58 |
Supplemental disclosure of non-cash investing and financing activities | ||
Unpaid offering costs | 254 | 1,074 |
Purchases of property and equipment included in accounts payable and accrued liabilities and other current liabilities | 430 | 376 |
Issuance of warrants in conjunction with the execution of debt agreement | $ 0 | $ 96 |
The Company and Summary of Sign
The Company and Summary of Significant Accounting Policies | 6 Months Ended |
Jul. 02, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
The Company and Summary of Significant Accounting Policies | The Company and Summary of Significant Accounting Policies Quantenna Communications, Inc. (the “Company”) was incorporated in the State of Delaware on November 28, 2005. The Company designs, develops and markets advanced high-speed wireless communication solutions enabling wireless local area networking. The Company’s wireless communication solutions deliver high performance, speed, and reliability for wireless networks and devices. Reporting Calendar The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Sunday closest to December 31. Fiscal 2017 will have 52 weeks and fiscal 2016 had 53 weeks. In a 52-week year, each fiscal quarter consists of 13 weeks. Fiscal 2017 will end on December 31, 2017. Initial Public Offering On October 27, 2016, the Company’s registration statement on Form S-1 relating to its initial public offering (“IPO”) of its common stock was declared effective by the U.S. Securities and Exchange Commission (“SEC”) and the shares of its common stock began trading on the NASDAQ Global Select Market on October 28, 2016. The public offering price of the shares sold in the IPO was $16.00 per share. The IPO closed on November 2, 2016 and a second close occurred on November 25, 2016 , pursuant to which the Company sold 6,775,466 shares of common stock, including the sale of 75,466 shares of common stock to the underwriters upon their exercise of their option to purchase additional shares. The Company received net proceeds of approximately $97.4 million , after underwriting discounts, commissions and offering expenses. Immediately prior to the consummation of the IPO, all outstanding shares of convertible preferred stock and preferred stock warrants were converted into common stock and common stock warrants, respectively. Unaudited Interim Financial Information The accompanying interim condensed consolidated financial statements and related disclosures are unaudited and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“US GAAP”). The condensed consolidated results of operations for the three and six months ended July 2, 2017 are not necessarily indicative of the results to be expected for the full year or for any other future year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2017 filed with the SEC on March 1, 2017 (“2016 Annual Report on Form 10-K”). Use of Estimates Preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods covered by the financial statements and accompanying notes. Actual results could differ from those estimates. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Significant Accounting Policies During the three and six months ended July 2, 2017 , there have been no changes in our significant accounting policies as described in the Company’s 2016 Annual Report on Form 10-K, except as discussed below: Stock-based compensation The Company measures and recognizes compensation expense for all stock-based awards made to employees, directors and non-employees, based on estimated fair values recognized using the straight-line method over the requisite service period. On January 1, 2017, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting . Under this guidance, the Company elected the option to no longer apply a forfeiture rate to the stock-based compensation expense, but to record forfeitures when they occur, and, as a result, under the modified retrospective method of adoption the Company recorded an immaterial cumulative effect adjustment of $54,000 to the opening accumulated deficit on January 2, 2017. Marketable Securities Marketable securities consist primarily of highly liquid investments with maturities of greater than 90 days when purchased. We generally classify our marketable securities at the date of acquisition as available-for-sale. These securities are reported at fair value with the related unrealized gains and losses included in "Accumulated other comprehensive loss", a component of stockholders’ equity, net of tax. Any unrealized losses which are considered to be other-than-temporary impairments are recorded in "Other income (expense), net" in the Condensed Consolidated Statements of Operations. Realized gains (losses) on the sale of marketable securities are determined using the specific-identification method and recorded in "Other income (expense), net" in the Consolidated Statements of Operations. All of our available-for-sale investments are subject to a periodic impairment review. We record a charge to earnings when a decline in fair value is significantly below cost basis and judged to be other-than-temporary, or have other indicators of impairments. If the fair value of an available-for-sale investment is less than its amortized cost basis, an other-than-temporary impairment is triggered in circumstances where (1) we intend to sell the instrument, (2) it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis or (3) a credit loss exists where we do not expect to recover the entire amortized cost basis of the instrument. If we intend to sell or it is more likely than not that we will be required to sell the available-for-sale investment before recovery of its amortized cost basis, we recognize an other-than temporary impairment charge equal to the entire difference between the investment's amortized cost basis and its fair value. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 6 Months Ended |
Jul. 02, 2017 | |
Accounting Policies [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows - Restricted Cash , which requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flow. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period, but any adjustments must be reflected as of the beginning of the fiscal year that includes that interim period. The new standard must be adopted retrospectively. The adoption of this standard is not expected to have a material impact on the Company’s consolidated statements of cash flows. In October 2016, the FASB issued ASU No. 2016-17, Consolidation - Interests Held through Related Parties That Are under Common Control , to amend the consolidation guidance on how a reporting entity that is the single decision maker of a variable interest entity should treat indirect interests in the entity held through related parties that are under common control within the reporting entity when determining whether it is the primary beneficiary of that variable interest entity. The standard is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. The adoption of this standard did not have a material impact on the Company’s consolidated financial position and results of operations. In October 2016, the FASB issued ASU No. 2016-16, Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory , which requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of a fiscal year. The new standard must be adopted using a modified retrospective transition method which is a cumulative-effective adjustment to retained earnings as of the beginning of the first effective reporting period. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on its consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments , ASU No. 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The adoption of this standard is not expected to have a material impact on the Company’s consolidated statements of cash flows. In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASC 842”), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases today. ASC 842 supersedes the previous leases standard, ASC 840 Leases . The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on its consolidated financial statements. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities , which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU No. 2016-01 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) , which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . This ASU No. 2014-09 is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU No. 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In August 2015, FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date , which effectively delayed the adoption date by one year, to an effective date for public entities for annual and interim periods beginning after December 15, 2017. In March, April, May and December 2016, the FASB issued additional updates to the new revenue standard relating to reporting revenue on a gross versus net basis, identifying performance obligations and licensing arrangements, and narrow-scope improvements and practical expedients, respectively. The effective date of this additional update is the same as that of ASU No. 2014-09. The guidance permits the use of either a retrospective or cumulative effect transition method. The Company has not yet selected a transition method. The Company is still finalizing the analysis to quantify the adoption impact of the provisions of the new standard, but it does not currently expect it to have a material impact on its consolidated financial position or results of operations. Based on the evaluation of its current contracts and revenue streams, revenue will be recorded consistently under both the current and new standard. The FASB has issued, and may issue in the future, interpretive guidance which may cause the Company’s evaluation to change. The Company believes it is following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective the beginning of fiscal year 2018. |
Earnings Per Share
Earnings Per Share | 6 Months Ended |
Jul. 02, 2017 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The following table summarizes the Company’s computation of basic and diluted net income (loss) per share attributable to common stockholders of the Company: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands, except share and per share data) Net income (loss) $ 169 $ (234 ) $ (716 ) $ (1,949 ) Weighted-average shares outstanding 33,933,522 1,159,109 33,549,273 1,148,259 Less: weighted average shares subject to repurchase due to early exercise (52,483 ) (83,786 ) (55,495 ) (85,653 ) Weighted average shares used to compute basic net income (loss) per share 33,881,039 1,075,323 33,493,778 1,062,606 Dilutive effect of stock options, common stock warrants, ESPP and RSUs 4,594,411 — — — Weighted average shares used to compute basic and diluted net income (loss) per share 38,475,450 1,075,323 33,493,778 1,062,606 Net income (loss) per share: Basic $ 0.00 $ (0.22 ) $ (0.02 ) $ (1.83 ) Diluted $ 0.00 $ (0.22 ) $ (0.02 ) $ (1.83 ) The following potentially dilutive securities outstanding at the end of the periods have been excluded from the computation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, Convertible preferred stock (as-converted) — 24,790,650 — 24,790,650 Warrants to purchase convertible preferred stock — 38,748 — 38,748 Warrants to purchase common stock — 438,656 153,256 438,656 Shares available for Employee Stock Purchase Plan (“ESPP”) 25,900 — 186,107 — Restricted Stock Units (“RSUs”) 104,723 — 913,117 — Options to purchase common stock 685,300 5,129,360 5,874,297 5,129,360 Total 815,923 30,397,414 7,126,777 30,397,414 |
Balance Sheets Components
Balance Sheets Components | 6 Months Ended |
Jul. 02, 2017 | |
Balance Sheets Components [Abstract] | |
Balance Sheets Components | Balance Sheets Components Marketable Securities Marketable securities at July 2, 2017 consisted of the following: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) Corporate debt securities $ 59,917 $ 5 $ (36 ) $ 59,886 Government debt securities 6,273 — (1 ) 6,272 $ 66,190 $ 5 $ (37 ) $ 66,158 The contractual maturities of marketable securities as of July 2, 2017 were as follows: Amortized Cost Fair Value (in thousands) Due in one year or less $ 29,974 $ 29,963 Due after one year to five years 36,216 36,195 $ 66,190 $ 66,158 There were no marketable securities as of January 1, 2017 . Property and Equipment, Net Property and equipment, net consisted of the following: July 2, January 1, (in thousands) Computer and lab equipment $ 12,337 $ 9,748 Computer software 645 625 Furniture and fixtures 179 136 Leasehold improvements 228 218 13,389 10,727 Accumulated depreciation and amortization (7,009 ) (5,985 ) Property and equipment, net $ 6,380 $ 4,742 Depreciation and amortization expense related to property and equipment was $0.5 million and $0.3 million , respectively, for the three months ended July 2, 2017 and June 26, 2016 , and $1.0 million and $0.5 million , respectively, for the six months ended July 2, 2017 and June 26, 2016 . Inventory Inventory consisted of the following: July 2, January 1, (in thousands) Raw materials $ 9,662 $ 9,067 Work in progress 3,623 1,128 Finished goods 7,700 5,625 $ 20,985 $ 15,820 Accrued Liabilities and Other Current Liabilities Accrued liabilities and other current liabilities consisted of the following: July 2, January 1, (in thousands) Accrued payroll and related benefits $ 2,897 $ 2,842 Accrued customer rebates 8,751 3,026 Accrual for inventory purchases 1,087 1,353 Accrued expenses 7,271 2,952 ESPP employee contributions 585 665 Other 1,430 963 $ 22,021 $ 11,801 |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jul. 02, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company determines fair value measurements used in its consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (i) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (ii) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. Level 2: Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3: Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We obtain the fair value of our Level 1 investments in money market funds, at the expected market price. These investments are expected to maintain a net asset value of $1 per share. We determine the fair value of our Level 2 financial instruments from third-party asset managers, custodian banks, and the accounting service providers. We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. There were no assets or liabilities in Level 3 of the fair value hierarchy and there were no transfers between Level 1 and Level 2 categories during any of the periods presented. We utilize the market approach to measure the fair value of our fixed income securities. The market approach is a valuation technique that uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The fair value of our fixed income securities is obtained using readily-available market prices from a variety of industry standard data providers, large financial institutions and other third-party sources for the identical underlying securities. Assets Measured at Fair Value on a Recurring Basis We measure and report certain assets at fair value at July 2, 2017 on a recurring basis as follows: Fair Value as of July 2, 2017 Level 1 Level 2 Level 3 Total Assets: (in thousands) Cash equivalents: Money market funds $ 22,185 $ — $ — $ 22,185 Corporate debt securities — 6,798 — 6,798 Government debt securities — 4,995 — 4,995 Total cash equivalents 22,185 11,793 — 33,978 Marketable Securities: — Corporate debt securities — 59,886 — 59,886 Government debt securities — 6,272 — 6,272 Total marketable securities — 66,158 — 66,158 Total cash equivalents and marketable securities $ 22,185 $ 77,951 $ — $ 100,136 The Level 1 assets consist of money market funds. The Level 2 assets consist of available-for-sale investment portfolio, which are valued utilizing a market approach. At January 1, 2017 , highly liquid money market funds of $100.9 million , respectively, were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets and were included in cash equivalents. Common Stock Warrants As of July 2, 2017 , warrants issued and outstanding were as follows: Date of Issuance Number of Warrants Exercise Price Expiration Date Common stock warrants September 2015 133,005 $ 2.50 February 2019 Common stock warrants February 2016 20,251 $ 4.00 February 2019 As of January 1, 2017 , warrants issued and outstanding were as follows: Date of Issuance Number of Warrants Exercise Price Expiration Date Common stock warrants October 2013 38,748 $ 7.74 October 2023 Common stock warrants September 2015 283,005 $ 2.50 February 2019 Common stock warrants February 2016 20,251 $ 4.00 February 2019 Common stock warrants February 2016 9,000 $ 0.05 January 2018 Common stock warrants May 2016 126,400 $ 4.00 May 2026 During the six months ended July 2, 2017 , common stock warrant issued in September 2015 to an investor of the Company was partially exercised at $2.50 per share and warrants issued in May 2016 to a lender at $4.00 per share were partially exercised and the remainder were canceled. During the six months ended July 2, 2017 , common stock warrants issued in October 2013 to another lender and in February 2016 to a service provider of the Company were exercised at $7.74 and $0.05 per share, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jul. 02, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Leases The Company conducts its operations using leased office facilities in various locations. The following is a schedule of future minimum lease payments under operating leases as of July 2, 2017 (in thousands): 2017 (remaining six months) $ 369 2018 1,756 2019 1,570 2020 1,580 2021 1,630 2022 and beyond 3,659 Total minimum lease payments $ 10,564 The Company leases office space under arrangements expiring through 2026. Rent expense for the three months ended July 2, 2017 and June 26, 2016 was $0.4 million and $0.3 million respectively. Rent expense for the six months ended July 2, 2017 and June 26, 2016 was $0.7 million and $0.6 million , respectively. In February 2017, the Company entered into a new lease agreement for its corporate headquarters located in San Jose, California consisting of approximately 84,000 square feet. The lease term is 76 months commencing on October 1, 2017 and expiring in 2024. Purchase Commitments The Company has purchase obligations of $34.6 million that are based on outstanding purchase orders as of July 2, 2017 , related to the fabrication of certain wafers for which production has started. These purchase orders are cancellable at any time, provided that the Company is required to pay all costs incurred through the cancellation date. Historically, the Company has rarely canceled these agreements once production has started. The Company did not otherwise have any outstanding non-cancellable purchase obligations as of July 2, 2017 . Indemnification In connection with the sale of its semiconductor products, the Company executes standard software license agreements allowing customers to use its firmware. Under the indemnification clauses of these license agreements, the Company agrees to defend the licensee against third-party claims asserting infringement by the Company’s products of certain intellectual property rights, which may include patents, copyrights, trademarks or trade secrets, and to pay any judgments entered on such claims against the licensee, subject to certain restrictions and limitations. The Company has never incurred significant expense defending its licensees against third-party claims. Further, the Company has never incurred significant expense under its standard product or services performance warranties. As a result, the Company believes the estimated fair value of these agreements is minimal. Accordingly, the Company has no liabilities recorded for these agreements at July 2, 2017 . Commitments In April 2012, an agreement was entered into with Joint Stock Company “RUSNANO” (formerly Open Joint Stock Company “RUSNANO”), which required the Company to form a wholly-owned subsidiary in the Russian Federation and to provide funding to the subsidiary in the three years following April 16, 2012. This wholly-owned subsidiary performs research and development activities for the Company. Funding means cash transfers to the subsidiary for equity investments, reimbursements of subsidiary operating expenses and Company expenses related to the subsidiary. RUSNANO also requires participation in subsidiary financial decisions. In July 2014, the Company entered into an amended and restated letter agreement with RUSNANO pursuant to which the Company agreed, among other matters, to operate and fund its Russian operations in an aggregate amount of $13.0 million over six annual periods beginning on December 31, 2014. The annual funding requirements in period one to period six are $2.2 million , $1.7 million , $2.0 million , $2.2 million , $2.4 million , and $2.5 million , respectively. In the event that the Company fails to meet its funding obligations for any period, it will be required to pay RUSNANO a penalty fee of 10% on 80% of the difference between the funding obligation and the actual funding for that period, subject to a cure period of one calendar quarter after the applicable period funding deadline. As of July 2, 2017 , the Company had met the minimum funding requirements and no penalty had been incurred. Legal Matters From time to time, the Company is a party to litigation and subject to claims incident to the ordinary course of business, including intellectual property claims, labor and employment claims, breach of contract claims, and other matters. Significant judgment is required when we assess the likelihood of any adverse judgments or outcomes to a potential claim or legal proceeding, as well as potential ranges of probable losses, and when the outcomes of the claims or proceedings are probable and reasonably estimable. Because of uncertainties related to these matters, we base our estimates on the information available at the time. As additional information becomes available, we reassess the potential liability related to pending claims and litigation, and may revise our estimates. Any revisions in the estimates of potential liabilities could have a material impact on the Company’s results of operations, financial position, and cash flows. In October 2016, Innovatio IP Ventures, LLC filed suit in the United States District Court for the Northern District of Illinois alleging infringement by the Company of nine expired U.S. patents. The complaint seeks unspecified damages. The lawsuit is in the early stages and the Company has not accrued for a loss relating to such matter because the Company believes that, although an unfavorable outcome may be possible, it is not considered at this time to be probable and the loss or range of loss is not reasonably estimable. |
Long-term Debt
Long-term Debt | 6 Months Ended |
Jul. 02, 2017 | |
Debt Disclosure [Abstract] | |
Long-term Debt | Long-term Debt Loan and Security Agreement The Company’s Loan and Security Agreement with SVB includes (i) term loans, (ii) revolving line of credit, and (iii) Mezzanine loan. The term loans have interest at a floating rate per annum equal to prime plus 0.75% . The revolving line of credit has interest between 4.25% to 5.00% depending on the Company’s consolidated leverage ratio, and the Mezzanine Loan has interest at a fixed rate per annum equal to 10.5% . The Mezzanine loan remained unused by the Company and was canceled upon its expiration in May 2017. The outstanding balance on the term loans was $5.0 million as of July 2, 2017 . The Company has an undrawn balance on the revolving line of credit of $20.0 million which can be drawn subject to 80% of eligible accounts receivable. The agreement contains usual and customary events of default upon the occurrence of certain events, such as nonpayment of amounts due under the revolving line of credit or the term loans, violation of the restrictive covenants, violation of other contractual provisions, or a material adverse change in its business. The agreement includes customary administrative covenants, including a prohibition on declaring dividends, but does not include any financial maintenance or operating related covenants. The amended and restated Loan and Security Agreement (the “SVB Loan and Security Agreement”) is collateralized by certain of the Company’s assets, including pledges of certain of the Company’s equity interests in its subsidiaries, receivables and inventory, subject to customary exceptions and limits. The SVB Loan and Security Agreement contains customary events of default upon the occurrence of certain events, such as nonpayment of amounts due under the revolving line of credit or the term loans, violation of restrictive covenants, violation of other contractual provisions, or a material adverse change in the Company’s business. In addition, the credit facilities prohibit the payment of cash dividends on the Company’s capital stock and also place restrictions on mergers, sales of assets, investments, incurrence of liens, incurrence of indebtedness and transactions with affiliates. The amended and restated Loan and Security Agreement has certain prepayment premium upon repayment before the maturity date. As of July 2, 2017 , future minimum payments for the long-term debt are as follows (in thousands): Long-term debt 2017 $ 1,396 2018 2,383 2019 1,618 Total minimum payments 5,397 Less: Amount representing interest (237 ) Less: Amount representing closing and repayment fees (210 ) Present value of minimum payments 4,950 Less: Unamortized debt discounts (80 ) Plus: Accretion of closing and repayment fees 138 Long-term debt, net 5,008 Less: Long-term debt, current portion 2,563 Non-current portion of long-term debt $ 2,445 |
Stockholders_ Equity
Stockholders’ Equity | 6 Months Ended |
Jul. 02, 2017 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Common Stock The Company’s Certificate of Incorporation, as amended, authorizes the Company to issue 1,000,000,000 shares of $0.0001 par value common stock. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of preferred stock outstanding. The Company has never declared any dividends. The Company had reserved shares of common stock for issuance, on an as-converted basis, as follows: July 2, 2017 Options issued and outstanding 5,874,297 RSUs issued and outstanding 913,117 Common stock warrants 153,256 Shares available for ESPP 1,835,341 Shares available for future stock awards 3,048,134 11,824,145 During the six months ended July 2, 2017 , the Company granted 937,158 RSUs to employees and 516,750 options. There were no RSUs granted and 233,775 options granted during the six months ended June 26, 2016 . Options Subject to Repurchase The Company has a right of repurchase with respect to unvested shares issued upon early exercise of options at an amount equal to the lower of (i) the exercise price of each restricted share being repurchased and (ii) the fair market value of such restricted share at the time the Company’s right of repurchase is exercised. The Company’s right to repurchase these shares lapses as to 1/36 of the total number of shares originally granted per month for 36 months . At July 2, 2017 , 50,000 shares remained subject to the Company’s right of repurchase. The shares purchased by employees pursuant to the early exercise of stock options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules. The cash received in exchange for unvested shares of early exercised stock options is recorded as an early exercise liability on the balance sheets and will be transferred to common stock and additional paid-in capital as such shares vest. |
Stock-based Compensation
Stock-based Compensation | 6 Months Ended |
Jul. 02, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-based Compensation | Stock-based Compensation Total stock-based compensation expense for employees and non-employees recognized in the condensed consolidated statements of operations was as follows: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands) Cost of revenue $ 42 $ 3 $ 85 $ 6 Research and development 1,414 122 2,619 223 Sales and marketing 410 30 763 60 General and administrative 708 731 1,211 901 Total stock-based compensation expense $ 2,574 $ 886 $ 4,678 $ 1,190 The above stock-based compensation expense related to the following equity-based awards: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands) Stock options $ 881 $ 886 $ 1,681 $ 1,190 RSU awards 1,231 — 1,950 — ESPP shares 462 — 1,047 — Total stock-based compensation expense $ 2,574 $ 886 $ 4,678 $ 1,190 |
Income Taxes
Income Taxes | 6 Months Ended |
Jul. 02, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company recorded an income tax expense of $0.2 million and $0.7 million for the three and six months ended July 2, 2017 . The Company’s quarterly income taxes reflect an estimate of the corresponding fiscal year’s annual effective tax rate and include, when applicable, adjustments from discrete tax items. As of July 2, 2017 , based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets will not be realized for federal and state purposes. Accordingly, management has applied a full valuation allowance against its federal and state net deferred tax assets at July 2, 2017 . Due to improvements in the United States operating results over the past three years, the Company believes a reasonable possibility exists that, within the next 12 months, sufficient positive evidence may become available to reach a conclusion that the valuation allowance against its federal and state net deferred tax assets will no longer be needed. Under Internal Revenue Code Section 382, our ability to utilize NOL carry-forwards or other tax attributes such as research tax credits, in any taxable year may be limited if we experience, or have experienced, an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of our stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. No net deferred tax assets have been recognized on the Company’s balance sheet related to its NOLs and tax credits, as they are fully reserved by a valuation allowance. The Company may have previously experienced, and may in the future experience, one or more Section 382 “ownership changes,” including in connection with its initial public offering. If so, or if the Company does not generate sufficient taxable income, it may not be able to utilize a material portion of its NOLs and tax credits even if it achieves profitability. If the Company is limited in its ability to use its NOLs and tax credits in future years in which it has taxable income, it will pay more taxes than if it were able to fully utilize its NOLs and tax credits. This could adversely affect the Company’s results of operations. |
Employee Benefit Plans
Employee Benefit Plans | 6 Months Ended |
Jul. 02, 2017 | |
Compensation and Retirement Disclosure [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans Defined Contribution Plan The Company adopted a 401(k) Plan that qualifies as a deferred compensation arrangement under Section 401 of the Internal Revenue Code. Under the 401(k) Plan, participating employees may defer a portion of their pretax earnings not to exceed the maximum amount allowable. The 401(k) Plan permits the Company to make matching contributions and profit sharing contributions to eligible participants. The Company has made matching contributions of $0.3 million for the six months ended July 2, 2017 . |
Related Party transactions
Related Party transactions | 6 Months Ended |
Jul. 02, 2017 | |
Related Party Transactions [Abstract] | |
Related Party transactions | Related Party Transactions Purchases from Cadence Design Systems, Inc. Lip-Bu Tan, a member of the Company’s board of directors since June 2015, is the President and Chief Executive Officer of Cadence Design Systems, Inc. (“Cadence”), an electronic design automation software and engineering services company. Since 2012, the Company has paid licensing fees for digital and analog layout tools and simulation tools from Cadence in the ordinary course of business. The Company incurred fees of approximately $0.7 million and $0.3 million under the terms of this arrangement during the three months ended July 2, 2017 and June 26, 2016 , respectively, and approximately $1.8 million and $0.6 million during the six months ended July 2, 2017 and June 26, 2016 , respectively. |
The Company and Summary of Si19
The Company and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jul. 02, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Reporting Calendar | Reporting Calendar The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Sunday closest to December 31. Fiscal 2017 will have 52 weeks and fiscal 2016 had 53 weeks. In a 52-week year, each fiscal quarter consists of 13 weeks. |
Use of Estimates | Use of Estimates Preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods covered by the financial statements and accompanying notes. Actual results could differ from those estimates. |
Principles of Consolidation | Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. |
New Accounting Pronouncements | Recent Accounting Pronouncements In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows - Restricted Cash , which requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flow. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period, but any adjustments must be reflected as of the beginning of the fiscal year that includes that interim period. The new standard must be adopted retrospectively. The adoption of this standard is not expected to have a material impact on the Company’s consolidated statements of cash flows. In October 2016, the FASB issued ASU No. 2016-17, Consolidation - Interests Held through Related Parties That Are under Common Control , to amend the consolidation guidance on how a reporting entity that is the single decision maker of a variable interest entity should treat indirect interests in the entity held through related parties that are under common control within the reporting entity when determining whether it is the primary beneficiary of that variable interest entity. The standard is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. The adoption of this standard did not have a material impact on the Company’s consolidated financial position and results of operations. In October 2016, the FASB issued ASU No. 2016-16, Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory , which requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of a fiscal year. The new standard must be adopted using a modified retrospective transition method which is a cumulative-effective adjustment to retained earnings as of the beginning of the first effective reporting period. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on its consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments , ASU No. 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The adoption of this standard is not expected to have a material impact on the Company’s consolidated statements of cash flows. In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASC 842”), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases today. ASC 842 supersedes the previous leases standard, ASC 840 Leases . The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the effects, if any, that the adoption of this guidance will have on its consolidated financial statements. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities , which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU No. 2016-01 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) , which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . This ASU No. 2014-09 is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU No. 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In August 2015, FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date , which effectively delayed the adoption date by one year, to an effective date for public entities for annual and interim periods beginning after December 15, 2017. In March, April, May and December 2016, the FASB issued additional updates to the new revenue standard relating to reporting revenue on a gross versus net basis, identifying performance obligations and licensing arrangements, and narrow-scope improvements and practical expedients, respectively. The effective date of this additional update is the same as that of ASU No. 2014-09. The guidance permits the use of either a retrospective or cumulative effect transition method. The Company has not yet selected a transition method. The Company is still finalizing the analysis to quantify the adoption impact of the provisions of the new standard, but it does not currently expect it to have a material impact on its consolidated financial position or results of operations. Based on the evaluation of its current contracts and revenue streams, revenue will be recorded consistently under both the current and new standard. The FASB has issued, and may issue in the future, interpretive guidance which may cause the Company’s evaluation to change. The Company believes it is following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective the beginning of fiscal year 2018. |
Fair Value Measurement | The Company determines fair value measurements used in its consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (i) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (ii) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. Level 2: Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3: Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We obtain the fair value of our Level 1 investments in money market funds, at the expected market price. These investments are expected to maintain a net asset value of $1 per share. We determine the fair value of our Level 2 financial instruments from third-party asset managers, custodian banks, and the accounting service providers. We classify financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. There were no assets or liabilities in Level 3 of the fair value hierarchy and there were no transfers between Level 1 and Level 2 categories during any of the periods presented. We utilize the market approach to measure the fair value of our fixed income securities. The market approach is a valuation technique that uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The fair value of our fixed income securities is obtained using readily-available market prices from a variety of industry standard data providers, large financial institutions and other third-party sources for the identical underlying securities |
Stock-based Compensation | Stock-based compensation The Company measures and recognizes compensation expense for all stock-based awards made to employees, directors and non-employees, based on estimated fair values recognized using the straight-line method over the requisite service period. On January 1, 2017, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting . Under this guidance, the Company elected the option to no longer apply a forfeiture rate to the stock-based compensation expense, but to record forfeitures when they occur, and, as a result, under the modified retrospective method of adoption the Company recorded an immaterial cumulative effect adjustment of $54,000 to the opening accumulated deficit on January 2, 2017. |
Marketable Securities | Marketable Securities Marketable securities consist primarily of highly liquid investments with maturities of greater than 90 days when purchased. We generally classify our marketable securities at the date of acquisition as available-for-sale. These securities are reported at fair value with the related unrealized gains and losses included in "Accumulated other comprehensive loss", a component of stockholders’ equity, net of tax. Any unrealized losses which are considered to be other-than-temporary impairments are recorded in "Other income (expense), net" in the Condensed Consolidated Statements of Operations. Realized gains (losses) on the sale of marketable securities are determined using the specific-identification method and recorded in "Other income (expense), net" in the Consolidated Statements of Operations. All of our available-for-sale investments are subject to a periodic impairment review. We record a charge to earnings when a decline in fair value is significantly below cost basis and judged to be other-than-temporary, or have other indicators of impairments. If the fair value of an available-for-sale investment is less than its amortized cost basis, an other-than-temporary impairment is triggered in circumstances where (1) we intend to sell the instrument, (2) it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis or (3) a credit loss exists where we do not expect to recover the entire amortized cost basis of the instrument. If we intend to sell or it is more likely than not that we will be required to sell the available-for-sale investment before recovery of its amortized cost basis, we recognize an other-than temporary impairment charge equal to the entire difference between the investment's amortized cost basis and its fair value. |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table summarizes the Company’s computation of basic and diluted net income (loss) per share attributable to common stockholders of the Company: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands, except share and per share data) Net income (loss) $ 169 $ (234 ) $ (716 ) $ (1,949 ) Weighted-average shares outstanding 33,933,522 1,159,109 33,549,273 1,148,259 Less: weighted average shares subject to repurchase due to early exercise (52,483 ) (83,786 ) (55,495 ) (85,653 ) Weighted average shares used to compute basic net income (loss) per share 33,881,039 1,075,323 33,493,778 1,062,606 Dilutive effect of stock options, common stock warrants, ESPP and RSUs 4,594,411 — — — Weighted average shares used to compute basic and diluted net income (loss) per share 38,475,450 1,075,323 33,493,778 1,062,606 Net income (loss) per share: Basic $ 0.00 $ (0.22 ) $ (0.02 ) $ (1.83 ) Diluted $ 0.00 $ (0.22 ) $ (0.02 ) $ (1.83 ) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following potentially dilutive securities outstanding at the end of the periods have been excluded from the computation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, Convertible preferred stock (as-converted) — 24,790,650 — 24,790,650 Warrants to purchase convertible preferred stock — 38,748 — 38,748 Warrants to purchase common stock — 438,656 153,256 438,656 Shares available for Employee Stock Purchase Plan (“ESPP”) 25,900 — 186,107 — Restricted Stock Units (“RSUs”) 104,723 — 913,117 — Options to purchase common stock 685,300 5,129,360 5,874,297 5,129,360 Total 815,923 30,397,414 7,126,777 30,397,414 |
Balance Sheets Components (Tabl
Balance Sheets Components (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Balance Sheets Components [Abstract] | |
Marketable Securities | Marketable securities at July 2, 2017 consisted of the following: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) Corporate debt securities $ 59,917 $ 5 $ (36 ) $ 59,886 Government debt securities 6,273 — (1 ) 6,272 $ 66,190 $ 5 $ (37 ) $ 66,158 Marketable securities at July 2, 2017 consisted of the following: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) Corporate debt securities $ 59,917 $ 5 $ (36 ) $ 59,886 Government debt securities 6,273 — (1 ) 6,272 $ 66,190 $ 5 $ (37 ) $ 66,158 The contractual maturities of marketable securities as of July 2, 2017 were as follows: Amortized Cost Fair Value (in thousands) Due in one year or less $ 29,974 $ 29,963 Due after one year to five years 36,216 36,195 $ 66,190 $ 66,158 |
Schedule of Property and Equipment | Property and equipment, net consisted of the following: July 2, January 1, (in thousands) Computer and lab equipment $ 12,337 $ 9,748 Computer software 645 625 Furniture and fixtures 179 136 Leasehold improvements 228 218 13,389 10,727 Accumulated depreciation and amortization (7,009 ) (5,985 ) Property and equipment, net $ 6,380 $ 4,742 |
Schedule of Inventory | Inventory consisted of the following: July 2, January 1, (in thousands) Raw materials $ 9,662 $ 9,067 Work in progress 3,623 1,128 Finished goods 7,700 5,625 $ 20,985 $ 15,820 |
Other Current Liabilities | Accrued liabilities and other current liabilities consisted of the following: July 2, January 1, (in thousands) Accrued payroll and related benefits $ 2,897 $ 2,842 Accrued customer rebates 8,751 3,026 Accrual for inventory purchases 1,087 1,353 Accrued expenses 7,271 2,952 ESPP employee contributions 585 665 Other 1,430 963 $ 22,021 $ 11,801 |
Schedule of Accrued Liabilities | Accrued liabilities and other current liabilities consisted of the following: July 2, January 1, (in thousands) Accrued payroll and related benefits $ 2,897 $ 2,842 Accrued customer rebates 8,751 3,026 Accrual for inventory purchases 1,087 1,353 Accrued expenses 7,271 2,952 ESPP employee contributions 585 665 Other 1,430 963 $ 22,021 $ 11,801 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value, Assets Measured on Recurring Basis | We measure and report certain assets at fair value at July 2, 2017 on a recurring basis as follows: Fair Value as of July 2, 2017 Level 1 Level 2 Level 3 Total Assets: (in thousands) Cash equivalents: Money market funds $ 22,185 $ — $ — $ 22,185 Corporate debt securities — 6,798 — 6,798 Government debt securities — 4,995 — 4,995 Total cash equivalents 22,185 11,793 — 33,978 Marketable Securities: — Corporate debt securities — 59,886 — 59,886 Government debt securities — 6,272 — 6,272 Total marketable securities — 66,158 — 66,158 Total cash equivalents and marketable securities $ 22,185 $ 77,951 $ — $ 100,136 |
Schedule of Warrants | As of July 2, 2017 , warrants issued and outstanding were as follows: Date of Issuance Number of Warrants Exercise Price Expiration Date Common stock warrants September 2015 133,005 $ 2.50 February 2019 Common stock warrants February 2016 20,251 $ 4.00 February 2019 As of January 1, 2017 , warrants issued and outstanding were as follows: Date of Issuance Number of Warrants Exercise Price Expiration Date Common stock warrants October 2013 38,748 $ 7.74 October 2023 Common stock warrants September 2015 283,005 $ 2.50 February 2019 Common stock warrants February 2016 20,251 $ 4.00 February 2019 Common stock warrants February 2016 9,000 $ 0.05 January 2018 Common stock warrants May 2016 126,400 $ 4.00 May 2026 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Future Minimum Rental Payments for Operating Leases | The following is a schedule of future minimum lease payments under operating leases as of July 2, 2017 (in thousands): 2017 (remaining six months) $ 369 2018 1,756 2019 1,570 2020 1,580 2021 1,630 2022 and beyond 3,659 Total minimum lease payments $ 10,564 |
Long-term Debt (Tables)
Long-term Debt (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Debt Disclosure [Abstract] | |
Schedule of Maturities of Long-term Debt | As of July 2, 2017 , future minimum payments for the long-term debt are as follows (in thousands): Long-term debt 2017 $ 1,396 2018 2,383 2019 1,618 Total minimum payments 5,397 Less: Amount representing interest (237 ) Less: Amount representing closing and repayment fees (210 ) Present value of minimum payments 4,950 Less: Unamortized debt discounts (80 ) Plus: Accretion of closing and repayment fees 138 Long-term debt, net 5,008 Less: Long-term debt, current portion 2,563 Non-current portion of long-term debt $ 2,445 |
Stockholders_ Equity (Tables)
Stockholders’ Equity (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Equity [Abstract] | |
Schedule of Stock by Class | The Company had reserved shares of common stock for issuance, on an as-converted basis, as follows: July 2, 2017 Options issued and outstanding 5,874,297 RSUs issued and outstanding 913,117 Common stock warrants 153,256 Shares available for ESPP 1,835,341 Shares available for future stock awards 3,048,134 11,824,145 |
Stock-based Compensation (Table
Stock-based Compensation (Tables) | 6 Months Ended |
Jul. 02, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Total stock-based compensation expense for employees and non-employees recognized in the condensed consolidated statements of operations was as follows: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands) Cost of revenue $ 42 $ 3 $ 85 $ 6 Research and development 1,414 122 2,619 223 Sales and marketing 410 30 763 60 General and administrative 708 731 1,211 901 Total stock-based compensation expense $ 2,574 $ 886 $ 4,678 $ 1,190 The above stock-based compensation expense related to the following equity-based awards: Three Months Ended Six Months Ended July 2, June 26, July 2, June 26, (in thousands) Stock options $ 881 $ 886 $ 1,681 $ 1,190 RSU awards 1,231 — 1,950 — ESPP shares 462 — 1,047 — Total stock-based compensation expense $ 2,574 $ 886 $ 4,678 $ 1,190 |
The Company and Summary of Si27
The Company and Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | ||
Nov. 25, 2016 | Jan. 01, 2017 | Oct. 27, 2016 | |
IPO | |||
Subsidiary, Sale of Stock [Line Items] | |||
Sale of stock price (USD per share) | $ 16 | ||
Number of shares issued (in shares) | 6,775,466 | ||
Consideration received | $ 97,400 | ||
IPO | Underwriters | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of shares issued (in shares) | 75,466 | ||
New Accounting Pronouncement, Early Adoption, Effect | Accounting Standards Update 2016-09 | |||
Subsidiary, Sale of Stock [Line Items] | |||
Deferred income tax liabilities, net | $ 54,000 | ||
New Accounting Pronouncement, Early Adoption, Effect | Accounting Standards Update 2016-09 | Accumulated Deficit | |||
Subsidiary, Sale of Stock [Line Items] | |||
Cumulative effect of new accounting principle in period of adoption | $ 54,000 |
Earnings Per Share (Schedule of
Earnings Per Share (Schedule of Eanings Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Earnings Per Share [Abstract] | ||||
Net income (loss) | $ 169 | $ (234) | $ (716) | $ (1,949) |
Weighted average shares used to compute basic and diluted net income (loss) per share: | ||||
Weighted-average shares outstanding (in shares) | 33,933,522 | 1,159,109 | 33,549,273 | 1,148,259 |
Less: weighted average shares subject to repurchase due to early exercise (in shares) | (52,483) | (83,786) | (55,495) | (85,653) |
Weighted average shares used to compute basic net income (loss) per share (in shares) | 33,881,039 | 1,075,323 | 33,493,778 | 1,062,606 |
Dilutive effect of stock options, common stock warrants, and RSUs (in shares) | 4,594,411 | 0 | 0 | 0 |
Weighted average shares used to compute basic and diluted net income (loss) per share (in shares) | 38,475,450 | 1,075,323 | 33,493,778 | 1,062,606 |
Net income (loss) per share: | ||||
Basic (usd per share) | $ 0 | $ (0.22) | $ (0.02) | $ (1.83) |
Diluted (usd per share) | $ 0 | $ (0.22) | $ (0.02) | $ (1.83) |
Earnings Per Share (Schedule 29
Earnings Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) - shares | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 815,923 | 30,397,414 | 7,126,777 | 30,397,414 |
Convertible preferred stock (as-converted) | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 0 | 24,790,650 | 0 | 24,790,650 |
Warrants to purchase convertible preferred stock | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 0 | 38,748 | 0 | 38,748 |
Warrants to purchase common stock | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 0 | 438,656 | 153,256 | 438,656 |
Shares available for Employee Stock Purchase Plan (“ESPP”) | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 25,900 | 0 | 186,107 | 0 |
Restricted Stock Units (“RSUs”) | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 104,723 | 0 | 913,117 | 0 |
Options to purchase common stock | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation (in shares) | 685,300 | 5,129,360 | 5,874,297 | 5,129,360 |
Balance Sheets Components (Mark
Balance Sheets Components (Marketable Securities) (Details) $ in Thousands | Jul. 02, 2017USD ($) |
Schedule of Investments [Line Items] | |
Amortized Cost | $ 66,190 |
Gross Unrealized Gains | 5 |
Gross Unrealized Losses | (37) |
Fair Value | 66,158 |
Corporate debt securities | |
Schedule of Investments [Line Items] | |
Amortized Cost | 59,917 |
Gross Unrealized Gains | 5 |
Gross Unrealized Losses | (36) |
Fair Value | 59,886 |
Government debt securities | |
Schedule of Investments [Line Items] | |
Amortized Cost | 6,273 |
Gross Unrealized Gains | 0 |
Gross Unrealized Losses | (1) |
Fair Value | $ 6,272 |
Balance Sheets Components (Amor
Balance Sheets Components (Amortized Cost and Fair Value) (Details) $ in Thousands | Jul. 02, 2017USD ($) |
Amortized Cost | |
Due in one year or less | $ 29,974 |
Due after one year to five years | 36,216 |
Total, amortized cost basis | 66,190 |
Fair Value | |
Due in one year or less | 29,963 |
Due after one year to five years | 36,195 |
Total, fair value | $ 66,158 |
Balance Sheets Components (Sche
Balance Sheets Components (Schedule of Property and Equipment) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | Jan. 01, 2017 | |
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 13,389 | $ 13,389 | $ 10,727 | ||
Accumulated depreciation and amortization | (7,009) | (7,009) | (5,985) | ||
Property and equipment, net | 6,380 | 6,380 | 4,742 | ||
Depreciation and amortization | 500 | $ 300 | 1,024 | $ 537 | |
Computer and lab equipment | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 12,337 | 12,337 | 9,748 | ||
Computer software | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 645 | 645 | 625 | ||
Furniture and fixtures | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 179 | 179 | 136 | ||
Leasehold improvements | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 228 | $ 228 | $ 218 |
Balance Sheets Components (Sc33
Balance Sheets Components (Schedule of Inventory) (Details) - USD ($) $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Balance Sheets Components [Abstract] | ||
Raw materials | $ 9,662 | $ 9,067 |
Work in progress | 3,623 | 1,128 |
Finished goods | 7,700 | 5,625 |
Inventory, gross | $ 20,985 | $ 15,820 |
Balance Sheets Components (Accr
Balance Sheets Components (Accrued Liabilities and Other Current Liabilities) (Details) - USD ($) $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Balance Sheets Components [Abstract] | ||
Accrued payroll and related benefits | $ 2,897 | $ 2,842 |
Accrued customer rebates | 8,751 | 3,026 |
Accrual for inventory purchases | 1,087 | 1,353 |
Accrued expenses | 7,271 | 2,952 |
ESPP employee contributions | 585 | 665 |
Other | 1,430 | 963 |
Accrued liabilities and other current liabilities | $ 22,021 | $ 11,801 |
Fair Value Measurements (Assets
Fair Value Measurements (Assets, Recurring Basis) (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 33,978 | |
Marketable securities | 66,158 | |
Total cash equivalents and marketable securities | 100,136 | |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 22,185 | $ 100,900 |
Marketable securities | 0 | |
Total cash equivalents and marketable securities | 22,185 | |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 11,793 | |
Marketable securities | 66,158 | |
Total cash equivalents and marketable securities | 77,951 | |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | |
Total cash equivalents and marketable securities | 0 | |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 22,185 | |
Money market funds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 22,185 | |
Money market funds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Money market funds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 6,798 | |
Marketable securities | 59,886 | |
Corporate debt securities | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | |
Corporate debt securities | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 6,798 | |
Marketable securities | 59,886 | |
Corporate debt securities | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | |
Government debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 4,995 | |
Marketable securities | 6,272 | |
Government debt securities | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | |
Government debt securities | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 4,995 | |
Marketable securities | 6,272 | |
Government debt securities | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | $ 0 |
Fair Value Measurements (Narrat
Fair Value Measurements (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Fair Value, Measurements, Recurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | $ 33,978 | |
Level 1 | Fair Value, Measurements, Recurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | $ 22,185 | $ 100,900 |
Common Stock Warrants - Issued May 2016 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Exercise price (USD per share) | $ 4 | |
Common Stock Warrants - Issued October 2013 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Exercise price (USD per share) | $ 7.74 | $ 7.74 |
Warrant | Common Stock Warrants - Issued May 2016 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Exercise price (USD per share) | $ 4 |
Fair Value Measurements (Schedu
Fair Value Measurements (Schedule of Warrants) (Details) - $ / shares | Jul. 02, 2017 | Jan. 01, 2017 |
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 153,256 | |
Common Stock Warrants - Issued October 2013 | ||
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 38,747.5 | |
Number of warrants issued (in shares) | 38,747.5 | |
Exercise price (USD per share) | $ 7.74 | $ 7.74 |
Common Stock Warrants - Issued September 2015 | ||
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 133,005 | 283,004.52 |
Number of warrants issued (in shares) | 133,005 | 283,004.52 |
Exercise price (USD per share) | $ 2.50 | $ 2.50 |
Common Stock Warrants - Issued February 2016 | ||
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 20,251 | 20,251 |
Number of warrants issued (in shares) | 20,251 | 20,251 |
Exercise price (USD per share) | $ 4 | $ 4 |
Common Stock Warrants - Issued February 2016 | ||
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 9,000 | |
Number of warrants issued (in shares) | 9,000 | |
Exercise price (USD per share) | $ 0.05 | |
Common Stock Warrants - Issued May 2016 | ||
Class of Warrant or Right [Line Items] | ||
Number of warrants outstanding (in shares) | 126,400 | |
Number of warrants issued (in shares) | 126,400 | |
Exercise price (USD per share) | $ 4 |
Commitments and Contingencies38
Commitments and Contingencies (Details) $ in Thousands | Jul. 02, 2017USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2017 (remaining six months) | $ 369 |
2,018 | 1,756 |
2,019 | 1,570 |
2,020 | 1,580 |
2,021 | 1,630 |
2022 and beyond | 3,659 |
Total minimum lease payments | $ 10,564 |
Commitments and Contingencies39
Commitments and Contingencies (Narrative) (Details) ft² in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | ||
Feb. 28, 2017ft² | Jul. 02, 2017USD ($) | Jun. 26, 2016USD ($) | Jul. 02, 2017USD ($) | Jun. 26, 2016USD ($) | |
Other Commitments [Line Items] | |||||
Rent expense | $ 400,000 | $ 300,000 | $ 700,000 | $ 600,000 | |
Area of real estate property | ft² | 84 | ||||
Term of lease | 76 months | ||||
Purchase obligation | 34,600,000 | 34,600,000 | |||
Indemnification Agreement | |||||
Other Commitments [Line Items] | |||||
Guarantor obligations | $ 0 | $ 0 |
Commitments and Contingencies40
Commitments and Contingencies (RUSNANO) (Details) - Investor - Agreement with RUSNANO | Jul. 02, 2017USD ($) | Dec. 31, 2014USD ($) | Jul. 31, 2014USD ($)period |
Related Party Transaction [Line Items] | |||
Contractual obligation | $ 13,000,000 | $ 13,000,000 | |
Annual periods | period | 6 | ||
Contractual obligation, year 1 | 2,200,000 | $ 2,200,000 | |
Contractual obligation, year 2 | 1,700,000 | 1,700,000 | |
Contractual obligation, year 3 | 2,000,000 | 2,000,000 | |
Contractual obligation, year 4 | 2,200,000 | 2,200,000 | |
Contractual obligation, year 5 | 2,400,000 | 2,400,000 | |
Contractual obligation, year 6 | $ 2,500,000 | $ 2,500,000 | |
Funding obligation penalty | 10.00% | ||
Difference between the funding obligation and the actual funding | 80.00% | ||
Funding obligation incurred | $ 0 |
Long-term Debt (Details)
Long-term Debt (Details) $ in Thousands | 6 Months Ended |
Jul. 02, 2017USD ($) | |
Debt Instrument [Line Items] | |
Long-term debt, gross | $ 5,397 |
Loans Payable | |
Debt Instrument [Line Items] | |
Basis spread on variable rate | 0.75% |
Long-term debt, gross | $ 5,000 |
Subordinated Debt | |
Debt Instrument [Line Items] | |
Stated interest rate | 10.50% |
Revolving Credit Facility | |
Debt Instrument [Line Items] | |
Remaining borrowing capacity | $ 20,000 |
Eligible accounts receivable percentage, maximum draw of credit line | 80.00% |
Revolving Credit Facility | Minimum | |
Debt Instrument [Line Items] | |
Line of credit interest rate during period | 4.25% |
Revolving Credit Facility | Maximum | |
Debt Instrument [Line Items] | |
Line of credit interest rate during period | 5.00% |
Long-term Debt (Schedule of Mat
Long-term Debt (Schedule of Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands | Jul. 02, 2017 | Jan. 01, 2017 |
Debt Disclosure [Abstract] | ||
2,017 | $ 1,396 | |
2,018 | 2,383 | |
2,019 | 1,618 | |
Total minimum payments | 5,397 | |
Less: Amount representing interest | (237) | |
Less: Amount representing closing and repayment fees | (210) | |
Present value of minimum payments | 4,950 | |
Less: Unamortized debt discounts | (80) | |
Plus: Accretion of closing and repayment fees | 138 | |
Long-term debt, net | 5,008 | |
Less: Long-term debt, current portion | 2,563 | $ 2,257 |
Non-current portion of long-term debt | $ 2,445 | $ 3,680 |
Stockholders_ Equity (Details)
Stockholders’ Equity (Details) | Jul. 02, 2017vote$ / sharesshares | Jan. 01, 2017$ / sharesshares |
Equity [Abstract] | ||
Common stock, shares authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, par value (usd per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Votes per share | vote | 1 | |
Options issued and outstanding (in shares) | 5,874,297 | |
Restricted Stock Units Issued and Outstanding | 913,117 | |
Common stock warrants (in shares) | 153,256 | |
Shares available for ESPP (in shares) | 1,835,341 | |
Shares available for future stock awards (in shares) | 3,048,134 | |
Shares reserved for future issuance (in shares) | 11,824,145 |
Stockholders_ Equity (Narrative
Stockholders’ Equity (Narrative 1) (Details) - shares | 6 Months Ended | |
Jul. 02, 2017 | Jun. 26, 2016 | |
Restricted Stock Units (“RSUs”) | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Grants in period (in shares) | 937,158 | 0 |
Stock options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Grants in period (in shares) | 516,750 | 233,775 |
Stockholders_ Equity (Narrati45
Stockholders’ Equity (Narrative 2) (Details) | 6 Months Ended |
Jul. 02, 2017shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Repurchase rights expiration per month of shares | 0.0278 |
Expiration period of repurchase program | 36 months |
Stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Remaining number of shares authorized to be repurchased | 50,000 |
Stock-based Compensation (Detai
Stock-based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | $ 2,574 | $ 886 | $ 4,678 | $ 1,190 |
Cost of revenue | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | 42 | 3 | 85 | 6 |
Research and development | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | 1,414 | 122 | 2,619 | 223 |
Sales and marketing | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | 410 | 30 | 763 | 60 |
General and administrative | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | $ 708 | $ 731 | $ 1,211 | $ 901 |
Stock-based Compensation (Equit
Stock-based Compensation (Equity Based Awards Compensation Costs) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | $ 2,574 | $ 886 | $ 4,678 | $ 1,190 |
Stock options | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | 881 | 886 | 1,681 | 1,190 |
RSU awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | 1,231 | 0 | 1,950 | 0 |
ESPP shares | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Total stock-based compensation expense | $ 462 | $ 0 | $ 1,047 | $ 0 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Income Tax Disclosure [Abstract] | ||||
Provision for income taxes | $ 210 | $ 21 | $ 744 | $ 38 |
Employee Benefit Plans (Details
Employee Benefit Plans (Details) $ in Millions | 6 Months Ended |
Jul. 02, 2017USD ($) | |
Compensation and Retirement Disclosure [Abstract] | |
Contribution amount by Company | $ 0.3 |
Related Party transactions (Nar
Related Party transactions (Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Jul. 02, 2017 | Jun. 26, 2016 | Jul. 02, 2017 | Jun. 26, 2016 | |
Lip-Bu Tan | ||||
Related Party Transaction [Line Items] | ||||
Purchases from related party | $ 0.7 | $ 0.3 | $ 1.8 | $ 0.6 |